Introduction {#s1}
============

In the first two decades of the 21st century, the proportion of individuals living with Alzheimer's disease (AD) \[AD (MIM: 104300)\] has been on the rise with an increasingly aging population. Today, two basic forms of AD exist, early-onset AD (EOAD) and late-onset AD (LOAD). EOAD correlates with the occurrence of mutations on specific genes that have given rise to inherited forms of the disease, whilst LOAD - which occurs later in life - has no specified etiology ([@B111]; [@B105]). Familial studies have identified a point mutation associated with EOAD on chromosome 21. This mutation is located in a gene called amyloid precursor protein (APP), and all members of these families show signs of the Alzheimer's phenotype at a relatively early stage of life ([@B126]). Novel mutations located on chromosomes 14 and 1 in genes encoding presenilin-1 and presenilin-2 have also been identified in EOAD ([@B54]). Unfortunately, specific genetic determinants that can explain the high prevalence of LOAD have yet to be identified.

Today we are aware that EOAD comprises only 1-3% of all AD cases ([@B111]; [@B105]; [@B18]). In LOAD subjects, disease prevalence changes with age; 5% after 65 years of age, 20% after 75 years of age, 30% after 80 years of age ([@B18]). Also women are twice as likely to suffer from AD than men ([@B90]). This prevalence is suggested to be due to differences in the life expectancy between males and females and to hormonal status ([@B120]; [@B90]). Studies with twins clearly signal that a strong genetic component is present in LOAD cases ([@B41]; [@B107]). Various genes have been implicated in AD and identified by using genetic approaches, such as Genome-Wide Association Studies (GWAS). However, the only "single gene" risk factor for LOAD without opposition in the research community concerns the gene encoding apolipoprotein E4 ([@B45]). In LOAD, the percentage of individuals carrying the at-risk allele of the ApoE4 gene was found to be between 20% and 70%, suggesting that there are additional genetic, and perhaps also epigenetic, factors that underlie the development of LOAD ([@B110]; [@B45]). Carrasquillo et al. ([@B23]) found that an alteration of a single-nucleotide polymorphism (SNP; rs5984894) on the Xq21.3 in a gene called protocadherin 11 (PCDH11X) in a cohort of women, was significantly associated with LOAD ([**Figure 1**](#f1){ref-type="fig"}). Other GWAS, however, have been unable to confirm the existence of these connections ([@B17]; [@B127]; [@B78]; [@B28]). We hypothesize that one of the possible answers to these observed genetic discrepancies is based on the epigenetics of the X chromosome.

![The genetic position of the PCDH11X on the X chromosome.](fgene-10-01368-g001){#f1}

We have previously identified centromere impairment or premature centromere separation (PCS) of the X chromosome in neuronal nuclei of the cerebral cortex in AD women ([@B115]). In addition, Yurov et al. discovered X chromosome aneuploidy in AD-affected neurons ([@B133]), which suggests that premature centromere separation is a mechanism of X chromosome instability ([@B115]). Epigenetically, chromosome X can be affected by skewed X chromosome inactivation, asynchronous replication patterns of the inactive X chromosome (Xi), X-inactivation escape, aneuploidy, and premature centromere separation. All these epigenetic X chromosome changes could potentially affect X chromosome genes through changes in sex chromosome dosage (SCD), and consequently promote AD pathogenesis ([@B3]; [@B52]; [@B1]; [@B115]; [@B58]; [@B83]; [@B133]; [@B10]; [@B15]; [@B67]; [@B50]). Raznahan et al. found recently that sex chromosome dosage not only influenced the adjacent sex chromosomes X and Y, but also autosomal gene expression ([@B97]).

The X Chromosome Is Unique {#s1_1}
--------------------------

In women, there is a systematic demand to compensate for SCD by silencing one of the copies of the X chromosome. With two X-chromosomes, women are more prone to inheriting potentially deleterious mutations in X-encoded genes, which, because of Xi, may all be expressed in different cells. The first finding of inactivation of the X chromosome was reported by [@B71]. It was found that one of the X chromosomes, paternal or maternal, was always inactivated, suggesting that an inactivation mechanism only allows active transcription at one X chromosome ([@B112]). This process of X-chromosome inactivation (XCI) evolved as a mechanism to regulate gene dosage. As a compensation mechanism, it does not affect all genes equally, and those genes that are not affected are known to escape XCI \[termed escapees; ([@B88])\].

Human embryos initially have non-random imprinted XCI, where the X-chromosome from the mother remains active, and XCI applies only to the X-chromosome inherited from the father. The imprint is not constant; XCI resets at the embryonic implantation stage. At this point the XCI reset leaves the maternal and paternal X open to random inactivation ([@B117]). Because XCI at this stage is random it causes most women to be mosaic for two cell lines, one harboring the active chromosome, the paternal X, and the other the maternal X. The randomness of this process causes an XCI ratio of approximately 50%:50% to be associated with the two cell lines in the female population. However, on rare occasions, in approximately 9% of the female population, a bias towards one of the two X chromosomes produces a skewed ratio (\> 80%:20%; ([@B6]). In this regard, Renault et al., analyzed the distribution of X-inactivation patterns (the relative abundance of the two cell populations) in a large cohort study of normal females, and reported that human XCI distribution pattern is more genetically influenced in comparison to the Xi model, which suggests a completely random selection of XCI ([@B100]).

The genetically influenced selection of XCI may be indicative of mutations in genes ([@B86]; [@B108]), suggesting the inactive X chromosome often harbors the mutated allele of an X-linked gene. This would mean that with a 50%:50% XCI ratio, wild type cells generally ameliorate disease phenotypes. Changes in the XCI ratio towards an increased expression of mutated genes can increase disease phenotype severity, as it is in the case of female hemophilia A ([@B99]), and sideroblastic anemia ([@B26]), where the majority of cells express the mutated allele. Changes in the XCI ratio where expression of the mutated allele is increased to exhibit the disease phenotype can also occur, as in Rett syndrome. In this case, the hemizygous mutation of the methyl-CpG--binding protein 2 (MeCP2) gene in males causes lethality, while the MeCP2 heterozygous mutation in females weakens such phenotypic consequences. It seems that the loss of MeCP2 function contributes to Rett syndrome, while the gain in MeCP2 dosage does not necessarily ameliorate the disease phenotype but may manifest as a less aggressive form in other neurological diseases. Increased expression of MeCP2 was found to be associated with other neurological diseases, such as AD and Huntington's disease ([@B5]; [@B9]; [@B76]; [@B74]).

Xi acquires several features of heterochromatin, such as hypermethylation, hypercondensation, altered replication patterns (late *vs.* early), and depletion of acetylated histones ([@B27]; [@B84]). Methylation patterns have been extensively used to determine the inactive chromosome ([@B108]), enabling an analysis of non-random inactivation processes in diseases that are X chromosome-linked ([@B128]). In our published study we suggest that changes in the inactivation patterns of the X-chromosome could have an impact on AD pathogenesis ([@B10]).

Brain and the X Chromosome {#s2}
==========================

The X chromosome harbors 3-5% of all the genes in a genome ([@B109]). There has been a debate on how many genes reside on the X chromosome and how many genes are expressed in the brain alone, compared to genes that are X-linked and expressed in the placenta, testes, muscles, and ovary. It is estimated that between 1,100 and 1,500 genes are present on the X chromosome ([@B109]; [@B66]). By using the Mart View software it was found that 1,500 X-linked genes are expressed in the brain, which represent numerous candidate genes that could be responsible for X-linked brain diseases ([@B66]). Many of the proteins expressed from the genes linked to the X chromosome represent channels, receptors, repair, transcription factors, and DNA/RNA binding proteins. Most of these proteins are located in the postsynaptic cleft and postsynaptic density (PSD) and are regulated through signaling complexes ([@B85]; [@B66]). It is intriguing that even if the X chromosome harbors 3-5% of all the genes, it is responsible for 10% of all diseases with Mendelian inheritance ([@B43]).

Another aspect that makes the X chromosome unique is that it harbors a higher proportion of brain-expressed miRNAs than would be expected ([@B49]), with 20% of these related to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus ([@B63]). Most of these miRNA are clustered, for example, miR532/188, miR-221/222, miR-98/Let7f, and miR-363/106a/20b/92a ([@B30]; [@B49]). Many of these are also intronic and it is believed that they are co-transcribed and co-expressed with other genes linked to chromosome X (deleted X-linked genes) and may be susceptible to SCD, skewing, and Xi escape processes. It is important to point out that inflammation and altered immunity are features of AD ([@B40]; [@B57]; [@B33]; [@B77]; [@B25]; [@B64]; [@B12]; [@B98]).

How these X-linked genes interact with genes controlling the immune system in AD is still unknown. For individual genes involved in diseases of the brain, a more complex hypothesis is that interplay occurs in disease genes embedded in multiprotein neuronal complexes. Many of the most important components of neuronal complexes are encoded on the X chromosome ([@B66]). Such complexes, which are essential for neuronal plasticity, cognitive processes, and cell signaling, are thought to be in the PSD cleft ([@B82]; [@B129]). Taking N-methyl-D-aspartate receptor/membrane-associated guanylate kinase-associated signaling complex/(NRC/MASC) as an example; combining its 185 proteins and with the other proteins in PSD gives a total of 1100 proteins. The X chromosome plays an essential role, and the percentage of genes related to synaptic plasticity, some 86% of all the genes in NRC/MASC are genes linked to chromosome X ([@B51]; [@B66]). It is interesting that these genes are also presented or expressed in human cognitive disorders ([@B51]; [@B91]; [@B37]; [@B118]). An analysis of the number of altered proteins in X-linked mental retardation disorders shows that from 69 genes currently known, 19 (or 28%) of these genes belong to postsynaptic proteins ([@B66]). The same pattern is conserved in the mouse X chromosome, and this suggests a network of multiprotein complexes functioning as integrated entities or complex molecular machines. If one component of this complex machinery is disrupted, the whole complex/network fails thus impairing the overall role of the multiprotein complex in processes of cognition ([@B51]; [@B85]; [@B91]; [@B66]; [@B37]; [@B118]).

X-Linked miRNA and the Brain {#s2_1}
----------------------------

The X chromosome is enriched in ncRNAs and harbors several miRNAs essential to brain function ([@B49]). It is important to note that miRNAs not only affect mRNA through translation repression but also work through other ncRNAs, such as lncRNAs and circRNAs, affecting downstream genes ([@B63]; [@B30]; [@B49]). Bian et al. revealed that a miRNA located on the X chromosome, a miR-374 family member, plays a role in cell growth and differentiation not only in various cancers, but also in AD. This miR-374 member is located at the X chromosome inactivation center and targets the VEGF, PTEN, Wnt, and Fas signaling pathways ([@B19]). Importantly, the PTEN pathway is of importance to the progression of AD through a mechanism that includes altered autophagy ([@B122]), mitophagy ([@B36]), and apoptosis ([@B29]). A report by Manzine et al. suggested that miR-374 directly targets the beta-secretase 1 to regulate the progress of AD, as the levels of miR-374 were significantly decreased in comparison to controls ([@B73]). In addition to miR-374, several miRNAs have also been found to correlate to X chromosome-linked intellectual disability syndrome, and among them are miR-223-3p, miR-362-5p, miR-504-5p.1, miR-361-5p, miR-505-3p.1 and miR-505-3p.2. All these miRNAs act as key regulators of genes linked to chromosome X but also of many autosomal intellectual disability genes that are connected in a complex network ([@B49]).

In the future, it is hoped that further work will reveal the extent to which genes on the X chromosome and miRNAs expressed in the brain, that together regulate processes including nervous system development, cell proliferation and transcription regulation, are altered by X chromosome skewing and asynchronous replication, which lead to aneuploidy and deregulation of cohesion dynamics in AD. Also, RNA genes that are linked to the X chromosome are prone to escape inactivation of the X chromosome ([@B87]). These epigenetic processes may prove to be gender-associated as research shows that expression of an X-linked miRNA in rheumatoid arthritis is more prevalent in women than in men ([@B63]).

PCDH11X {#s3}
=======

Carrasquillo et al. previously identified an SNP (rs 5984894) on the X chromosome (Xq21,3) in a gene called PCDH11X ([@B23]). This locus is associated with LOAD in women of European origin from the USA. The PCDH11X gene encodes the protein, protocadherin 11. Women who are homozygous for this SNP have a greater risk of developing AD, not only when compared to women without the SNP, but also when compared to women that are heterozygotes, and male hemizygotes ([@B23]). Zubenko et al. reported that the DXS1047 genotype is correlated with AD ([@B136]) and that this genotype is associated with the PCDH11X gene ([@B137]). The results from the same authors indicate an association between the variation in the PCDH11X gene and the risk of acquiring AD, but these results have not been confirmed in other GWAS ([@B17]; [@B127]; [@B78]). Our suggestion is that these discrepancies in GWAS results may well be due to the changes in the epigenetics of the X chromosome.

Does PCDH11X Escape X Inactivation? {#s3_1}
-----------------------------------

Pseudoautosomal genes and functional Y chromosome orthologues (X-linked genes with Y homology) tend to escape X inactivation ([@B32]; [@B21]). Sudbrak et al. reported that PCDH11X expression might also escape X inactivation, and this assumption was verified by using an X chromosome-specific cDNA microarray where elevated expression of PCDH11X was identified in cells expressing multiple X chromosomes ([@B116]). Lopes et al. indirectly found that PCDH11X expression was higher in women than in men by looking at CpG islands and their methylation patterns. By using bisulfite sequencing analysis, the same authors found the absence of CpG island methylation on both the active and the Xi chromosomes and that these processes coincide with possible PCDH11X escape from X inactivation ([@B68]). Another study found that PCDH11X can undergo asynchronous replication, and that PCDHX11 is also prone to escape the inactivation process ([@B124]). Replication asynchrony of the X pseudoautosomal locus has been identified ([@B121]), and suggests that other genes that replicate asynchronously are also prone to escape inactivation ([@B7]; [@B24]; [@B34]).

PCDH11X Asynchronous Replication {#s3_2}
--------------------------------

Xi is associated with a sequence of epigenetic modifications ([@B27]), and goes through a phase of changes involving DNA methylation and histone modification resulting in Xi condensation in a body called the Barr body. This results in changes in DNA replication -- more specifically, the Xi in the S phase replicates later than its active counterpart. Imperfect chromosome replication can be a consequence of "escapees" (genes that escape the inactivation process). Such genes include hypoxanthine-guanine phosphoribosyltransferase and Fragile X-chromosome genes that display asynchronicity. The X-inactive-specific transcript (Xist) gene (important for inactivation) that is expressed from the Xi also replicates asynchronously ([@B20]; [@B2]). Wilson et al. reported that PCDH11X displays replication asynchrony in both female and male cells ([@B124]). The data from these authors, together with those from others ([@B86]), show that a complex relationship exists between X-inactivation, replication asynchrony, and the status of expression of individual genes on chromosome X ([@B14]; [@B13]).

It thus appears that synchronous replication occurs more frequently than previously thought, and is found not only through imprinting, but also through randomized monoallelic expression, pathologies, and tandem duplications ([@B124]). Clinically, an increase in asynchronous replication increases the risk in women for aneuploidy ([@B4]). The relationship between centromere instability, control of replication, and nondisjunction are best exemplified by the fact that young women that have children with Down's syndrome have twice the risk of developing AD ([@B56]; [@B47]; [@B38]; [@B101]; [@B102]; [@B89]; [@B103]; [@B79]; [@B80]; [@B62]; [@B46]).

Chromosomes 21, X, and 18 were primarily affected, showing repeated non-disjunction and centromere impairment ([@B94]; [@B42]; [@B89]; [@B79]; [@B80]; [@B62]; [@B93]). We suggest that X chromosome replication asynchrony is likely to lead to accelerated instability of chromosome X in AD ([@B13]).

Sex Chromosome Dosage (SCD): an Engine of Stability {#s4}
===================================================

The crosstalk that exists between X chromosomes and autologous genes is a relatively new paradigm that has emerged as a result of the biology of sex differences, and gives rise to the question of how SCD shapes the genome function. To explore this, human sex aneuploidies were analyzed from a genome-wide expression dataset by Raznahan et al. where they found a dosage sensitivity of the X-Y chromosome pair resulting in increased expression of genes that decrease X/Y chromosomal dosage ([@B97]). The most interesting finding was that X-linked genes were found to regulate co-expression of networks of autosomal genes that are SCD-sensitive and, in addition to these findings, suggest that the autosomal genes and their corresponding networks are crucial for cellular functions. This highlights the potential of SCD to affect the occurrence of disease.

The most common aneuploidy in AD is XO mosaicism ([@B114]; [@B115]; [@B133]; [@B113]). In respect to SCD and the XO status, Raznahan et al. have demonstrated up-regulation of the protein networks, noncoding RNA metabolism, suppression of the cell cycle, changes in regulation of DNA/chromatin organization, glycolysis, and response to stress ([@B97]). Changes in these collective networks through XO and supernumerary XXY, and XXYY syndromes may enhance the risk of AD ([@B97]; [@B50]).

There is a small but constant number of neuronal cells that express a different number of chromosomes, such as aneuploidy ([@B60]; [@B131]; [@B61]; [@B59]; [@B133]), but also copy number variation on chromosome 21, which is crucial in AD ([@B22]), DNA content variation ([@B72]; [@B123]), and LINE elements ([@B35]).

Mosaic aneuploidy in the brain revealed that not only was chromosome 21 affected in AD, but also that the X chromosome was found to be supernumerary and presumed to be affected through a mechanism that involves altered cohesion/cohesin dynamics ([@B114]; [@B115]; [@B13]; [@B134]; [@B135]; [@B133]; [@B11]; [@B113]; [@B132]).

[@B133] suggested that chromosome 21 might not be the only chromosome to influence changes in genome stability of a neuron, which leads to a cascade of processes that result in neuronal loss. The finding that affected brains show a two-fold increase in X chromosome aneuploidy in the hippocampus and cerebrum - areas of the brain most affected by AD - suggesting that altered sex chromosome dosage plays a role in the large scale genomic variation in neuronal cells in AD compared to controls. These results have been recently corroborated by the finding that the sex chromosomes were distinct from autosomes in the dorsolateral prefrontal cortex and that X chromosome aneuploidy was associated with a faster rate of cognitive decline which is a hallmark of AD ([@B50]). Therefore, X chromosome aneuploidy may contribute to aging, but also to processes leading to pathological changes in brains affected by AD.

Previously we proposed the "post-mitotic state-maintained protein hypothesis" where we distinguished aneuploization in the brain as constitutional aneuploidy with non-pathological diversification of the neurons ([@B11]). These aneuploidogenic processes are balanced with cohesin and cohesion-related proteins. Alteration of this balance develops as a link between neuronal development and chromosomal instability, intracellular diversity and human brain diseases including AD ([@B58]). Looking closely at the overall somatic mosaicism found in the brain, we, together with others, suggest that micro aneuploidy or segmental aneuploidy is a more proper measure of changes in gene dosage leading to AD ([@B31]). These processes are heavily realized when looking at SCD effects on gene expression in humans ([@B97]).

An additional complexity of genome mosaicism in the brain relates to findings concerning DNA and gene copy number variations. Regional variations of DNA content has been identified with higher DNA content found in the frontal cortex and cerebellum compared with other brain regions ([@B123]). Copy number variations may be considered as an independent genetic factor not related to other genomic changes, suggesting its plays a role in neurodevelopmental disorders in patients with sex chromosome aneuploidies ([@B55]; [@B67]). It has been reported that 11% of neurons in the brain cortex exhibit a DNA content that is above the diploid level ([@B39]), and similar findings have also been reported in the AD brain ([@B119]; [@B8]; [@B130]; [@B16]). These somatic gene variations in neurons appear to be generated by chromosome segregation defects. Some of these cells are expelled by apoptosis, but several cells are introduced as a pool of variability of the neuronal genome. These cell populations are thus vulnerable in the sense that they are more prone to genome instability and thus may contribute to age-related mental disorders, such as AD. Gómez-Ramos et al. presented distinct X-chromosome single nucleotide variants from some sporadic AD samples ([@B48]). In samples from LOAD patients, a higher number of single nucleotide variants in genes present at the X chromosome were identified using exome sequencing compared to age-matched controls. Two genes that were not previously described as risk factors, UBE2NL and ATXN3L, were found to have variants important for the ubiquitin pathway in LOAD ([@B48]).

Maintenance of the interphase state in neurons is an active process. The 3D organization of the genome is correlated to gene expression in the interphase. In the 3D domain, chromosomes occupy preferential positions by self-organizing into topologically-associated domains, which may change due to the cell lineage or stage of the organism ([@B65]). There is a possible exchange between the inactive and active chromosome in gene regulatory information. Cohesin is indirectly associated with the Xi 3D position in the genome. Minajigil et al. reported that a reaction between Xist and cohesins results in the repulsion of the latter from Xi, thus changing its 3D shape ([@B81]). The Xi is much more complex, and it also represents a reservoir of genes that could replace mutated genes from the active X chromosome. At present, this untapped potential known as the X interactome requires further investigation ([@B81]). Progress in understanding the Xist interactome requires more understanding of how it is used and how epigenetically-regulated long ncRNAs potentially influence disease. By utilizing a specific technique named iDRiP, some 200 proteins in the Xist interactome were identified ([@B81]). Most of the proteins are from several categories, such as cohesins, condesins, topoisomerases, RNA helicase, histone modifiers, methyltransferases, nuclear matrix proteins, and nucleoskeletal factors. Cohesin may play a more important role in the complex relationship between the Xi and active X chromosome ([@B81]). Even though these processes are an important mechanism of diversity, alterations may lead to an increased structural and topological variation of the genome in the brain, enhancing the susceptibility of affected neurons to genome instability that may lead to AD ([@B11]; [@B50]; [@B132]).

A number of publications have reported mislocalization of some critical proteins responsible for chromatin organization and epigenetic modifications in brain diseases including AD ([@B44]; [@B69]; [@B70]; [@B95]; [@B53]; [@B75]; [@B92]; [@B106]; [@B125]).

All these data suggest, that in AD chromatin, organizers are deregulated and chromatin topology is changed in a manner that alters gene expression leading to synaptic dysfunction, a major pathological change in AD, and consequently neurodegeneration ([@B44]; [@B69]; [@B70]; [@B95]; [@B53]; [@B75]; [@B92]; [@B106]; [@B125]).

Xist RNA can act as a scaffold for proteins required to maintain the inactive state of neurons. It has been shown that it can act as a repulsion mechanism that expels architectural factors such as cohesins in order to avoid unwanted chromatin conformation that could increase unfavorable transcription ([@B97]). Minajigi et al. suggest that Xi RNA plays an important role in the organization of how chromosomes are regulated into chromosome territories and that Xi inactivation is fundamentally important in these processes ([@B81]). It could be suggested that X chromosome instability found in AD may result in changes in the Xi pattern, Xi escapees, SCD, and consequently changes in the topological organization, thus altering chromatin organization that may affect already other genes related to AD ([**Figure 2**](#f2){ref-type="fig"}).

![X chromosome instability, Sex Chromosome Dosage, Topological changes of Chromosomes, and its possible role in AD.](fgene-10-01368-g002){#f2}

The cohesin-associated protein, shugoshin-1, seems to be fundamental in repressing the accumulation of amyloid-β and Tau phosphorylation in shugoshin-1 gene (Sgo1) haploinsufficient mice ([@B96]).

Summary {#s5}
=======

Conflicting results from studies of the PCDH11X gene in AD could be explained by cohort size, ethnicity, and environmental factors *per se* but also by the influence of X chromosome epigenetics. Thus, GWAS of sex chromosomes should take into account any alterations of the epigenetic processes in the X chromosome ([@B104]).

The findings that chromosome X expresses all of the somatic genomic neuronal variability properties and can *de novo* express several epigenetic mechanisms suggest that the X chromosome instability phenotype may be viewed as an important risk factor in AD pathogenesis.
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